GlassScriptPhysician profile
Morgan Callahan
NPI 1639562622
$4,213.26
in general payments reported to CMS, 2019-2025
12 companies · $2,602 in 2025
The $2,602 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $703 · 2023: $294 · 2024: $614 · 2025: $2,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,600 · Food and Beverage: $1,475 · Travel and Lodging: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,600.00 |
| Food and Beverage | $1,474.55 |
| Travel and Lodging | $435.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,690.52 | 2022-2025 | Surgimend, Codman Certas, Primatrix |
| Allergan, INC. | $672.22 | 2022 | |
| Stryker Corporation | $502.28 | 2025 | 1788, Molli |
| Mentor Worldwide LLC | $373.15 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $278.79 | 2024-2025 | |
| Polynovo North America LLC | $175.20 | 2023 | |
| Davol INC. | $163.86 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $147.08 | 2024 | Pico |
| Abbvie INC. | $119.27 | 2023 | Natrelle Saline-Filled Breast Implants |
| Pacira Pharmaceuticals Incorporated | $50.54 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $23.92 | 2025 | |
| Solventum Corporation | $16.43 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Callahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.